Omicron variant-specific vaccine
Scope
Date
~
-
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
COVID treatment deals drive Samsung Bio’s record quarterly earnings
South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...
Jul 28, 2021 (Gmt+09:00)
-
Corporate bonds
Delta variant, rate hike views hurt Korean lower-rated corporate bond sales
South Korean companies with low credit ratings around BBB are suffering weaker demand in the primary market. A spread in the Delta coronavirus varia...
Jul 22, 2021 (Gmt+09:00)
-
Airlines
Korean LCCs continue to face worst market conditions in 2021
Korea’s low-cost carriers (LCCs) are projected to post another period of financial loss in the second quarter of 2021.According to analyst est...
Jul 22, 2021 (Gmt+09:00)
-
COVID-19
Celltrion’s COVID-19 treatment reduces incidence of severity by 70%
Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...
Jul 13, 2021 (Gmt+09:00)
language -
Markets
Delta coronavirus variant hits global stock markets
Global stock markets lost ground on mounting fears over the spread of the Delta coronavirus variant. Record-breaking US shares riding on the hopes...
Jul 09, 2021 (Gmt+09:00)
-
Central banking
Fed’s Powell, BOK chief to meet during G20 gathering
Federal Reserve Chair Jerome Powell and Bank of Korea (BOK) Governor Lee Ju-yeol will meet during a Group of 20 (G20) gathering of finance ministe...
Jul 09, 2021 (Gmt+09:00)
-
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Central bank
Bank of Korea governor sends stronger signal to raise rates this year
South Korea’s central bank governor on Friday flagged a tighter monetary policy for the second time in less than a month, fueling expectations...
Jun 11, 2021 (Gmt+09:00)
-
Korean stock market
Samsung returns as foreigners’ top pick; Kospi just shy of record high
Samsung Electronics Co., the bellwether of South Korea’s main bourse, has returned as the market darling, with foreigners buying heavily on th...
Jun 03, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience secures up to $173.4 mn from CEPI for vaccine development
SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...
May 24, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language -
COVID vaccines
Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine
South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...
May 12, 2021 (Gmt+09:00)
language -
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
COVID-19
Genexine exports COVID vaccine candidate to Indonesia
Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...
Apr 28, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience halts flu vaccine output to focus on COVID vaccines
South Korea’s SK Bioscience Co. is suspending production of SKYCellflu, an influenza vaccine, to focus on manufacturing COVID-19 vaccines inst...
Mar 30, 2021 (Gmt+09:00)
language -
COVID-19
Green Cross in talks with Russia to produce COVID-19 vaccine
South Korea’s pharmaceutical company Green Cross Corporation (GC) is holding a series of close meetings on contract manufacturing of Russia&rs...
Mar 18, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience eyes $900 mn annual sales from vaccine business
South Korea’s SK Bioscience Co. is looking to post 1 trillion won ($900 million) in annual revenue from its vaccine business as the biopharmac...
Feb 23, 2021 (Gmt+09:00)
language -
Celltrion eyes COVID-19 vaccine development
South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...
Feb 19, 2021 (Gmt+09:00)
language -
Economy
Korea’s treasury yields climb on hopes of vaccines, more bond issues
South Korea’s treasury yields are heading higher as advances in vaccine development and concerns over increased government bond sales prompt f...
Dec 20, 2020 (Gmt+09:00)
-
COVID-19
Korea Superfreeze readies for mass COVID-19 vaccine storage
It's a busy day at the Korea Superfreeze warehouse in South Korea's Gyeonggi province, with trucks entering and exiting the spacious 92,500-square...
Dec 14, 2020 (Gmt+09:00)
-
Cold-chain logistics
SK Holdings cryogenic biz eyes jackpot on hopes of imminent COVID-19 vaccine
South Korea's SK Holdings Co. may hit the jackpot with the development of a COVID-19 vaccine on the horizon.Once a coronavirus vaccine is available, t...
Nov 13, 2020 (Gmt+09:00)
-
COVID-19
SK Bioscience wins COVID-19 vaccine manufacturing order from US firm
SK Bioscience Co. Ltd. has secured a contract manufacturing organization (CMO) order for a new coronavirus vaccine candidate under development by the ...
Aug 14, 2020 (Gmt+09:00)